The use of an integrated opioid and medical marijuana prescription drug monitoring program
| Autor: | Nathaniel M. Rickles, Ladan Karim-Nejad, Sara Wakai |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Drug
medicine.medical_specialty media_common.quotation_subject education Integrated systems Pharmacist Pharmacology (nursing) Pharmacy Medical Marijuana Pharmacists 030226 pharmacology & pharmacy 03 medical and health sciences 0302 clinical medicine Marijuana use Humans Medicine 030212 general & internal medicine Prescription Drug Monitoring Program media_common Pharmacology business.industry Opioid-Related Disorders Analgesics Opioid Dispensary Opioid Family medicine Prescription Drug Monitoring Programs business medicine.drug |
| Zdroj: | Journal of the American Pharmacists Association. 61:408-417 |
| ISSN: | 1544-3191 |
| Popis: | Objectives To (1) identify the reasons for which pharmacists in Connecticut use the CPMRS when dispensing opioid medications and medical marijuana products, (2) determine pharmacists’ perceived value of the CPMRS when dispensing opioids or medical marijuana, and (3) compare practices and the perceived value of the CPMRS among community-based pharmacists (CBPs) and medical marijuana dispensary pharmacists (MMDPs). Methods An online survey was administered from May 2019 to June 2019 to CBPs (n = 178) and MMDPs (n = 12). The survey included items about background, use, and attitudes about current and future use of the CPMRS. Results Both pharmacist groups indicated that opioid use information was the most useful aspect of the CPMRS. Ninety percent of both groups checked patients’ use of opioids using the CPMRS, and 81.2% of the MMDPs compared with 38.4% of the CBPs indicated that they checked for patients’ use of medical marijuana. A greater percentage of MMDPs than CBPs felt that access to the marijuana use information was useful and needed for counseling. Several pharmacists recommended improvements in marijuana use information in the CPMRS and greater efficiencies for users of the system. Conclusion Access to both marijuana and opioid use information can allow pharmacists to make specific recommendations on the basis of potential drug interactions and dose adjustments. The results from the present study highlight how integrated systems of opioid and marijuana dispensing information can be further enhanced by resolving existing pharmacy barriers involving technology, workflow, and need for systems with more detailed marijuana product information. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|